← Back to Clinical Trials
Recruiting NCT05856786

NCT05856786 To Study the Effects of Refractive Surgery on OCT Measurements in the Eye

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05856786
Status Recruiting
Phase
Sponsor University of Nebraska
Condition Optical Coherence Tomography
Study Type OBSERVATIONAL
Enrollment 33 participants
Start Date 2024-06-01
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Optical coherence tomography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 33 participants in total. It began in 2024-06-01 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Corrective eye surgeries, such as Lasik, are widely used to correct focusing problems such as myopia, or nearsightedness. Often these patients develop other conditions like myopic maculopathy or glaucoma which require monitoring with optical coherence tomography (OCT). Since OCT is a light-based test and changes the refractive status of the eye (in the cornea or the lens), it can potentially affect the results of the OCT measurements but has not been sufficiently studied. This pilot study aims at studying the potential change in OCT parameters in the eye after undergoing such surgery.

Eligibility Criteria

Inclusion Criteria: 1. Patients undergoing refractive surgery 2. For patients undergoing bilateral eye surgery, the one with higher degree of ametropia will be included. Exclusion Criteria: 1. Astigmatism more than 3 Diopters 2. Visual acuity worse than 20/25 3. Patients with unstable visual fixation 4. Severe Dry Eye

Contact & Investigator

Central Contact

Pukhraj P Rishi, MBBS

✉ pukhraj.rishi@unmc.edu

📞 402-559-2020

Principal Investigator

Pukhraj P Rishi, MBBS

PRINCIPAL INVESTIGATOR

University of Nebraska

Frequently Asked Questions

Who can join the NCT05856786 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Optical Coherence Tomography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05856786 currently recruiting?

Yes, NCT05856786 is actively recruiting participants. Contact the research team at pukhraj.rishi@unmc.edu for enrollment information.

Where is the NCT05856786 trial being conducted?

This trial is being conducted at Omaha, United States.

Who is sponsoring the NCT05856786 clinical trial?

NCT05856786 is sponsored by University of Nebraska. The principal investigator is Pukhraj P Rishi, MBBS at University of Nebraska. The trial plans to enroll 33 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology